Literature DB >> 19200976

Expression of vascular endothelial growth factor receptors in the endometrium of septate uterus.

Francisco Raga1, Eva Maria Casañ2, Fernando Bonilla-Musoles3.   

Abstract

OBJECTIVE: To compare the messenger RNA (mRNA) expression of vascular endothelial growth factor (VEGF) receptors (KDR, Flt-1, and sflt) in the different endometrial locations of septate uterus and normal uterus.
DESIGN: Prospective, observational study.
SETTING: University teaching hospital. PATIENT(S): Twelve women with complete septate uterus undergoing hysteroscopic metroplasty and 12 women with normal uterus. INTERVENTION(S): Endometrial tissue samples were obtained from the endometrium covering the septum and the endometrium lining the lateral wall of the uterus. Moreover, endometrial samples were obtained from patients with normal uterus. MAIN OUTCOME MEASURE(S): Differences in the mRNA expression of VEGF receptors between the endometrial samples of septate and normal uterus. RESULT(S): The mRNA expression of VEGF receptors, both KDR and Flt-1, was significantly lower in the endometrium lining the septum as compared with the endometrium covering the lateral wall of septate and normal uterus. Conversely, no differences were observed in mRNA expression in the soluble receptor sflt between the different endometrial samples studied. CONCLUSION(S): The results suggest that a local defect of both VEGF transmembranous receptors (KDR and Flt-1) in the endometrium covering the septal area may be responsible for the clinical comportment of this müllerian anomaly.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19200976     DOI: 10.1016/j.fertnstert.2008.07.1768

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  6 in total

1.  Recurrent Miscarriage: Diagnostic and Therapeutic Procedures. Guideline of the DGGG (S1-Level, AWMF Registry No. 015/050, December 2013).

Authors:  B Toth; W Würfel; M K Bohlmann; G Gillessen-Kaesbach; F Nawroth; N Rogenhofer; C Tempfer; T Wischmann; M von Wolff
Journal:  Geburtshilfe Frauenheilkd       Date:  2015-11       Impact factor: 2.915

2.  Fertility and pregnancy outcomes following hysteroscopic metroplasty of different sized uterine septa: A retrospective cohort study protocol.

Authors:  Xi Wang; Haiyan Hou; Qi Yu
Journal:  Medicine (Baltimore)       Date:  2019-07       Impact factor: 1.817

3.  Recurrent Spontaneous Miscarriage: a Comparison of International Guidelines.

Authors:  Kilian Vomstein; Anna Aulitzky; Laura Strobel; Michael Bohlmann; Katharina Feil; Sabine Rudnik-Schöneborn; Johannes Zschocke; Bettina Toth
Journal:  Geburtshilfe Frauenheilkd       Date:  2021-04-23       Impact factor: 2.915

4.  Retrospective cohort study of the risk factors for secondary infertility following hysteroscopic metroplasty of the uterine septum in women with recurrent pregnancy loss.

Authors:  Shuichi Ono; Mirei Yonezawa; Kenichiro Watanabe; Takashi Abe; Katsuya Mine; Yoshimitsu Kuwabara; Shigeo Akira; Toshiyuki Takeshita
Journal:  Reprod Med Biol       Date:  2017-11-29

5.  Recurrent Miscarriage: Diagnostic and Therapeutic Procedures. Guideline of the DGGG, OEGGG and SGGG (S2k-Level, AWMF Registry Number 015/050).

Authors:  Bettina Toth; Wolfgang Würfel; Michael Bohlmann; Johannes Zschocke; Sabine Rudnik-Schöneborn; Frank Nawroth; Ekkehard Schleußner; Nina Rogenhofer; Tewes Wischmann; Michael von Wolff; Katharina Hancke; Sören von Otte; Ruben Kuon; Katharina Feil; Clemens Tempfer
Journal:  Geburtshilfe Frauenheilkd       Date:  2018-04-27       Impact factor: 2.915

6.  The randomised uterine septum transsection trial (TRUST): design and protocol.

Authors:  J F W Rikken; C R Kowalik; M H Emanuel; M Y Bongers; T Spinder; J H de Kruif; K W M Bloemenkamp; F W Jansen; S Veersema; A G M G J Mulders; A L Thurkow; K Hald; A Mohazzab; Y Khalaf; T J Clark; M Farrugia; H A van Vliet; M S Stephenson; F van der Veen; M van Wely; B W J Mol; M Goddijn
Journal:  BMC Womens Health       Date:  2018-10-05       Impact factor: 2.809

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.